Siroon Bekkering, theme Vascular damage, obtained a Dekker grant (209k euro) of the Dutch Heart Foundation. This competitive grant allows Siroon to perform her project 'Trained innate immunity at the level of bone marrow progenitors as driver of atherosclerosis development'.Siroon Bekkering studies how atherosclerosis progresses through the activation of the immune system. Cholesterol and other inflammatory molecules can activate the innate immune system and make it hyperactive (a process called trained immunity). These hyperactive immune cells are found in the circulation of patients with cardiovascular disease. In this project starting in March 2020 (in the research groups of Mihai Netea and Niels Riksen) Siroon will study specific subtypes and progenitors of innate immune cells and dive into the molecular mechanisms of this hyperactivity.
In 2018 Siroon obtained a Rubicon grant with her project: Young and obese: does inflammation cause the earlier onset of cardiovascular disease? For this project Siroon is now living in Australia and working at the Murdoch Children’s Research Institute, Royal Children’s Hospital, Melbourne, Australia (Department of Internal Medicine).
About her stay in Australia you can follow her vlog, which she has made for NWO.
Related news items
KWF Roadshow 11 November 201910 October 2019
In which way(s) can KWF provide optimal support to oncological research and care? How can we maximize impact on our investments? These questions are pivotal in Ambition 2030: the vision that KWF developed in close cooperation with stakeholders in the oncological field.read more
A personal touch of Frank Wagener10 October 2019
In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t. This week: Frank Wagener.read more
Dorine Swinkels collaborates with winners of the Nobel Prize in Physiology or Medicine9 October 2019
The Nobel Prize in Physiology or Medicine 2019 was awarded jointly to William G. Kaelin Jr, Sir Peter J. Ratcliffe and Gregg L. Semenza for their discoveries of how cells sense and adapt to oxygen availability.read more
Scaling up nanotherapy7 October 2019
Scaling up and translating nanotherapy from pre-clinical work in small animal models to a clinical application is not trivial. Raphael Duivenvoorden, theme Renal disorders, and colleagues, published their results on translating a new nanoimmunotherapy in the journal Science Translational Medicine.read more